(NASDAQ:ASPI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If […]
(NasdaqGM:APLT), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If
Report on how AI is redefining market landscape – The global copper marketsize is estimated to grow by USD 70 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. High demand for copper from APACis driving market growth,with a trend towardstechnological innovations driving
(NASDAQ:AZN), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the “Class Period”), of the February 21, 2025 lead plaintiff deadline in the securities class action
NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=124244&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=124243&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
By Maryanne Dell In the wake of the terrible wildfires that have devastated Pacific Palisades,Altadena, Malibu and several surrounding areas in Southern California, Centaurus Financial, Inc. recognizes the dire situation faced by many, including animals. It also recognizes the need to help. To that end, the Anaheim, California-based independent broker/dealer has donated $10,000 to Pasadena
Pomerantz LLP is investigating claims on behalf of investors ofTransMedics Group, Inc. (“TransMedics”or the “Company”)(NASDAQ: TMDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether TransMedics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information
(NASDAQ:AZN), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) in the United States District Court for the Central District of California on behalf of all
(NasdaqGM:PSNY), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Polestar Automotive Holding UK PLC (“Polestar” or the “Company”) (NASDAQ: PSNY) on behalf of Polestar stockholders. Our investigation concerns whether Polestar has violated the federal securities laws and/or engaged